https://ansm.sante.fr/tableau-acces-derogatoire/voraxaze-1000-u-poudre-pour-solution-pour-perfusion 2024 false false false France French glucarpidase drug information
--- https://www.has-sante.fr/jcms/p_3361532/fr/voraxaze-glucarpidase-reduction-de-la-concentration-plasmatique-toxique-de-methotrexate 2022 false false false France Methotrexate Toxicity Methotrexate Toxicity insurance, health, reimbursement treatment outcome adult adolescent child methotrexate methotrexate glucarpidase guidelines for drug use injections, intravenous evaluation of the transparency committee glucarpidase methotrexate Voraxaze
--- https://www.has-sante.fr/jcms/p_3334621/fr/voraxaze-glucarpidase https://www.has-sante.fr/jcms/p_3334731/fr/decision-n-2022-0235/dp/sem-du-25-avril-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-voraxaze 2022 false false false France treatment outcome insurance, health, reimbursement methotrexate Methotrexate Toxicity Methotrexate Toxicity adult child glucarpidase injections, intravenous evaluation of the transparency committee Voraxaze glucarpidase
--- https://www.ema.europa.eu/en/medicines/human/EPAR/voraxaze-0 2022 false false false Netherlands French English glucarpidase glucarpidase glucarpidase orphan drug production treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe adult adolescent infant aged Methotrexate toxicity methotrexate injections, intravenous methotrexate methotrexate product surveillance, postmarketing pregnancy breast feeding drug interactions drug evaluation, preclinical